Merck is heading into its second-quarter earnings report on Tuesday with important pillars of its business increasingly under ...

Merck has launched a sweeping cost-cutting effort designed to save $3 billion annually by the end of 2027, the company said ...

Facing an end to Keytruda's market exclusivity, the company will cut $3 billion in costs that it plans to redeploy in support ...

Global pharmaceutical company Merck (NYSE:MRK) met Wall Street’s revenue expectations in Q2 CY2025, but sales fell by 1.9% ...

CEO Rob Davis referred to the cost reduction program as a 'reallocation' rather than a cut, with the savings to be reinvested ...

German supplier of chemicals and materials used in making semiconductors, Merck KGaA , announced on Tuesday it is to invest 500 million euros in Taiwan over the next five to seven years, primarily ...